| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/23/2006 | US20060041144 Phenylpyridine compound and fungicidal compostion containing the same |
| 02/23/2006 | US20060041143 Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione |
| 02/23/2006 | US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides |
| 02/23/2006 | US20060041114 Activators for oligonucleotide synthesis |
| 02/23/2006 | US20060041020 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040988 antiinflammatory, antipyretic and analgesic agents; side effects redution; N-(cyclohexylmethyl)-6-[4-(methylsulfonyl)phenyl]-4-(trifluoromethyl)-2-pyridinamine; osteoarthritis; rheumatoid arthritis |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040902 Compunds useful as pesticides |
| 02/23/2006 | DE102004040016A1 Preparation of ionic liquids, useful as electrolytes, comprises reacting anion compounds with heterocyclic compounds and phosphor containing compounds, reacting the resulting product with e.g. ether and continuously isolating the product |
| 02/23/2006 | DE102004039486A1 Production of organic compounds of trace elements, e.g. zinc methionate for use as animal feed additive, involves the solid-state reaction of a metal oxide and a solid organic acid in a pulveriser, e.g. a vibration grinding mill |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 02/23/2006 | CA2575033A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/22/2006 | EP1626716A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | EP1208086B1 Benzamide formulation with histone deacetylase inhibitor activity |
| 02/22/2006 | CN1738884A Electrochromic compounds |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738796A Bis-aryl sulfonamides |
| 02/22/2006 | CN1738793A Compounds, compositions and methods |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1736994A Azo hetercyle beta-elemene derivative and its preparation method and uses |
| 02/22/2006 | CN1736991A Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses |
| 02/22/2006 | CN1736990A N-allyl-2-alkyl pyridinium chloride onium salt, its homopolymer and copolymer, and its preparation method |
| 02/22/2006 | CN1736989A Heterocyclicmethrin compound and its uses in weeding and sterilization |
| 02/22/2006 | CN1736988A [Di (2-picolyl) -amido]-aliphatic acid preparation method and its intermediate |
| 02/22/2006 | CN1736987A Bipyridine methylhistamine derivative and its chelate, and its preparation method |
| 02/22/2006 | CN1736986A Polyhydroxy stilbenes compound preparation and uses as drugs for suppressing SARS |
| 02/22/2006 | CN1736982A Process for the preparation of 4-haloalkylnicotinonitriles |
| 02/22/2006 | CN1736588A Supported catalyst for pyridine synthesis by tetrahydrofurfuryl alcohol and preparation process thereof |
| 02/22/2006 | CN1736587A Supported catalyst for pyridine synthesis by tetrahydrofurfuryl alcohol and preparation process thereof |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/22/2006 | CN1242975C Method of producing carboxylic acid salts |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002018 Process for the preparation of amorphous form of torsemide |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/21/2006 | US7001908 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/21/2006 | CA2267309C Use of 1-hydroxy-2-pyridones for the treatment of skin infections |
| 02/21/2006 | CA2098959C Compounds and methods for the site-specific photoaffinity labelling of biomolecules |
| 02/16/2006 | WO2006017406A1 Cyanoamidine p2x7 antagonists for the treatment of pain |
| 02/16/2006 | WO2006017148A2 Optically enhanced chiral ionic liquids |
| 02/16/2006 | WO2006016657A1 Drug for treating or preventing hcv infection |
| 02/16/2006 | WO2006016218A1 Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005112916A3 Bis-aryl sulfonamides |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/16/2006 | WO2005042475A3 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 02/16/2006 | WO2004112729A3 Dual function compounds and uses thereof |
| 02/16/2006 | WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/16/2006 | US20060036071 Processes for preparing eptifibatide |
| 02/16/2006 | US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | DE102004035322A1 Selektive Hemmstoffe humaner Corticoidsynthasen Selective inhibitors of human Corticoidsynthasen |
| 02/16/2006 | DE102004034543A1 Verfahren zur Herstellung von Onium-Salzen mit geringem Chlorid-Gehalt A process for the preparation of onium salts having a low chloride content |
| 02/16/2006 | CA2672687A1 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 02/16/2006 | CA2576254A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | CA2573078A1 Optically enhanced chiral ionic liquids |
| 02/15/2006 | EP1626045A1 Processes for producing 3-substituted 2-chloro-5-fluoropyridine or salt thereof |
| 02/15/2006 | EP1626041A2 New materials useful as electolytic solutes |
| 02/15/2006 | EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 02/15/2006 | EP1625115A1 Substituted pyrimidine derivatives |
| 02/15/2006 | EP1625112A1 Novel compounds for treatment of obesity |
| 02/15/2006 | EP1624868A1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl!phenyl derivatives as beta2 agonists |
| 02/15/2006 | EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
| 02/15/2006 | CN1735342A Small particle copper pyrithione |
| 02/15/2006 | CN1733757A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| 02/15/2006 | CN1733736A Azo aryl heterocycle diamines and its preparation method |
| 02/15/2006 | CN1733730A Iridium compound and organic electroluminescent device using the same |
| 02/15/2006 | CN1733729A 2,6-dimethylpyridine preparation method |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241907C Organic compounds |
| 02/14/2006 | US6998637 Circuit element having a first layer composed of an electrically insulating substrate material, a method for producing a circuit element, bispyridinium compounds and their use in circuit elements |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998411 2-Methylheptylisonicotinate and process for production thereof |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics |
| 02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
| 02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/09/2006 | WO2006015194A2 Preparation of pyridonecarboxylic acid antibacterials |